ArticleNutrition journal2025
Associations of urinary phytoestrogen biomarkers with uric acid and hyperuricemia, and the mediating role of kidney function.
Article in Nutrition journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundHyperuricemia is increasingly acknowledged as a major public health issue. Current evidence on the effects of urinary phytoestrogen biomarkers on hyperuricemia is limited. Moreover, the potential mediation effect of kidney function was not assessed.
methodsThis study included 2,793 adults aged 20–79 years from the National Health and Nutrition Examination Surveys (NHANES 2007–2010). We used traditional regression and Bayesian kernel machine regression (BKMR) models to assess the associations of urinary phytoestrogen biomarkers with serum uric acid and hyperuricemia risk, and the mediation effect model to evaluate the role of kidney function in their associations. Estimated glomerular filtration rate (eGFR) was calculated for assessing kidney function.
resultsMost phytoestrogen biomarkers were inversely associated with serum uric acid and hyperuricemia risk, with mean changes in the estimates ranging from − 0.06 to -0.12 mg/dl and odds ratios ranging from 0.80 to 0.90. The BKMR model demonstrated that higher urinary concentrations of phytoestrogen mixtures were associated with lower serum uric acid and hyperuricemia risk, and identified that equol (EQU) and enterolactone (ENT) were the two most important contributors to the overall inverse associations. The BKMR model further confirmed that EQU and ENT were independently associated with lower serum uric acid and hyperuricemia risk. Causal mediation analysis indicated eGFR mediated the associations of EQU and ENT with hyperuricemia risk, with the proportion of mediation ranging from 9.64 to 11.60% (all P < 0.05), respectively.
conclusionsUrinary phytoestrogen biomarkers were inversely associated with serum uric acid levels and the risk of hyperuricemia, with EQU and ENT identified as the major contributing metabolites. These findings provide preliminary evidence that renal function may partially mediate the associations of EQU and ENT with uric acid concentrations and hyperuricemia risk.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.